Stockscreener 앱 받기
0.3527
7.16%
-0.0272
시간 외 거래:
.38
0.0273
+7.74%
전일 마감가:
$0.3799
열려 있는:
$0.3658
하루 거래량:
509.79K
Relative Volume:
0.88
시가총액:
$20.60M
수익:
-
순이익/손실:
$-123.46M
주가수익비율:
-0.1362
EPS:
-2.59
순현금흐름:
$-104.11M
1주 성능:
+6.88%
1개월 성능:
-9.12%
6개월 성능:
-21.41%
1년 성능:
-76.01%
1일 변동 폭
$0.3419
$0.3886
1주일 범위
$0.33
$0.3886
52주 변동 폭
$0.2601
$2.525
바이오아틀라 Stock (BCAB) Company Profile
명칭
Bioatla Inc
전화
858-558-0708
주소
11085 TORREYANA ROAD, SAN DIEGO
BCAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.3527 | 21.88M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
바이오아틀라 Stock (BCAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | 개시 | JMP Securities | Mkt Outperform |
| 2022-05-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-06-28 | 개시 | ROTH Capital | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | BTIG Research | Buy |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | JP Morgan | Overweight |
| 2021-01-11 | 개시 | Jefferies | Buy |
모두보기
바이오아틀라 주식(BCAB)의 최신 뉴스
BioAtla Inc. stock trend outlook and recovery pathFree Stable Entry High Return Opportunities - Newser
Using data filters to optimize entry into BioAtla Inc.Entry Optimization Tool with Screener Logic - Newser
What institutional flow reveals about BioAtla Inc.Automated AI Forecast with Trading Alerts - Newser
Does BioAtla Inc. stock have upside surprise potentialDaily Breakout Recap Watch - sisaissue.com
What technical models suggest about BioAtla Inc.’s comebackFree Alpha Driven Watchlist With Alerts - Newser
Head-To-Head Review: Alzamend Neuro (NASDAQ:ALZN) & BioAtla (NASDAQ:BCAB) - Defense World
Sector ETF performance correlation with BioAtla Inc.Free Alpha Driven Watchlist With Alerts - Newser
Comparing BioAtla Inc. in custom built stock radarsFree Swing Setup With Technical Confirmation - Newser
BioAtla's Strategic Position in Immuno-Oncology and Partnership-Driven Growth - AInvest
Why BioAtla Inc. stock attracts strong analyst attentionSwing Trade Signal and Price Prediction - Newser
BioAtla August 2025 slides: promising clinical data amid financial headwinds By Investing.com - Investing.com Nigeria
Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts - Investing.com
BioAtla August 2025 slides: promising clinical data amid financial headwinds - Investing.com
BioAtla Inc Reports Q2 2025 EPS of -$0.32, Missing Estimates; Net Loss at $18.7 Million - AInvest
BioAtla faces Nasdaq delisting over share price rule - MSN
BioAtla Inc (BCAB) Q2 2025 Earnings Call Highlights: Promising Clinical Progress Amid Financial ... By GuruFocus - Investing.com Canada
BioAtla, Inc. Reports Q2 2025 Financial Results and Clinical Progress - TipRanks
Bioatla Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : BioAtla, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
BioAtla, Inc. SEC 10-Q Report - TradingView
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress - The Manila Times
BioAtla Q2 FY23: $ revenue, financial results, conference call August 7, 2025. - AInvest
Top Risks to Consider Before Buying BioAtla Inc. StockBreakout Watcher with Entry and Exit Alerts - Newser
Automated trading signals detected on BioAtla Inc.High Accuracy Trade Setup Identification - Newser
What makes BioAtla Inc. stock price move sharplyDaily Technical Chart Pattern Analysis Report - Newser
BioAtla to Announce Second Quarter 2025 Financial Results and Provide Business Highlights on August 7, 2025 - The Manila Times
Clinical-Stage Biotech BioAtla Sets Q2 Earnings Date: Key Updates on CAB Cancer Therapeutics Expected - Stock Titan
Is BioAtla Inc. stock overvalued or undervaluedMarket-beating performance - Jammu Links News
How many analysts rate BioAtla Inc. as a “Buy”Achieve breakthrough performance with smart picks - Jammu Links News
How volatile is BioAtla Inc. stock compared to the marketTurn volatility into profit opportunities - Jammu Links News
What is the risk reward ratio of investing in BioAtla Inc. stockExplosive capital appreciation - Jammu Links News
Is it the right time to buy BioAtla Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
Should I hold or sell BioAtla Inc. stock in 2025Massive wealth growth - Jammu Links News
Published on: 2025-08-02 01:56:13 - Newser
바이오아틀라 (BCAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):